Product image of Momendol (Naproxen Sodium) supplied by GNH India

Momendol

Active Ingredient:
Naproxen Sodium
Origin:
EU

Momendol (Naproxen Sodium)

Naproxen sodium, the active ingredient in Momendol, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It provides analgesic, anti‑inflammatory and antipyretic effects for the relief of pain, inflammation and fever in adult patients and is commonly prescribed for musculoskeletal conditions.

GNH India supplies Momendol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved products to health‑care providers across multiple regions.

Manufacturer / TM Owner

Angelini Pharma S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Naproxen sodium is an NSAID that reduces inflammation and pain by inhibiting cyclooxygenase enzymes.

  • Osteoarthritis: alleviates joint pain and improves function.
  • Rheumatoid arthritis: decreases joint swelling and stiffness.
  • Acute musculoskeletal pain: provides rapid pain relief.
  • Fever: lowers elevated body temperature.

How It Works

  • Naproxen sodium exerts its effect by non‑selectively inhibiting cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes, which are key in the conversion of arachidonic acid to prostaglandins. By reducing prostaglandin synthesis, it diminishes inflammation, nociceptive signaling, and the hypothalamic set‑point for temperature, resulting in analgesic, anti‑inflammatory and antipyretic actions.

Side Effects

Adverse reactions to naproxen sodium may vary in frequency and severity.

Common Side Effects

  • Gastrointestinal upset: dyspepsia, heartburn, or abdominal discomfort.
  • Nausea: feeling of queasiness often accompanying oral intake.
  • Headache: mild to moderate head pain.
  • Dizziness: transient sense of light‑headedness.

Serious or Rare Side Effects

  • Gastrointestinal bleeding or ulceration: potentially life‑threatening hemorrhage.
  • Renal impairment: reduced kidney function or acute kidney injury.
  • Cardiovascular events: increased risk of heart attack or stroke.
  • Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Precautions & Warnings

When prescribing naproxen sodium, clinicians should consider several safety aspects.

  • Assess gastrointestinal risk: evaluate history of ulcers or bleeding.
  • Monitor renal function: especially in patients with kidney disease.
  • Evaluate cardiovascular status: use cautiously in those with heart disease.
  • Use lowest effective dose: limit duration to reduce adverse events.
  • Avoid in known hypersensitivity: discontinue if allergic reaction occurs.
  • Store at room temperature: keep in original packaging, protect from moisture.

Avoid Interactions

Naproxen sodium can affect the pharmacokinetics or pharmacodynamics of several medicines.

Major Interactions (Avoid)

  • Anticoagulants (e.g., warfarin): increased bleeding risk.
  • Other NSAIDs or aspirin: additive gastrointestinal toxicity.
  • Selective serotonin reuptake inhibitors (SSRIs): heightened hemorrhagic potential.
  • ACE inhibitors or ARBs: possible reduction in renal function.
  • Lithium: elevated lithium serum levels.

Moderate Interactions (Monitor Closely)

  • Diuretics: may impair renal clearance.
  • Corticosteroids: enhanced risk of ulceration.
  • Methotrexate: reduced elimination leading to toxicity.
  • Antihypertensives: possible attenuation of blood‑pressure control.
  • Oral hypoglycemics: potential alteration of glucose control.

Frequently Asked Questions

Momendol contains naproxen sodium, an NSAID indicated for the relief of mild to moderate pain, reduction of inflammation, and lowering of fever. It is commonly prescribed for conditions such as osteoarthritis, rheumatoid arthritis, acute musculoskeletal pain, and febrile states.

Naproxen sodium works by non‑selectively blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. Lower prostaglandin levels reduce inflammation, diminish pain signaling, and reset the hypothalamic temperature set‑point, providing analgesic, anti‑inflammatory, and antipyretic effects.

The appropriate dose of Momendol is determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and overall health status. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for naproxen sodium in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and only under the supervision of a qualified healthcare provider.

To order Momendol, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with ibuprofen, another NSAID, naproxen sodium has a longer half‑life, allowing less frequent dosing. Both share similar efficacy for pain and inflammation, but naproxen may carry a slightly higher risk of gastrointestinal irritation, while ibuprofen is often preferred for short‑term use.

Momendol should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Momendol is administered orally. The tablets (or other oral dosage form) should be swallowed whole with a full glass of water, preferably with food or milk to lessen potential stomach irritation.

Serious risks include gastrointestinal bleeding or ulceration, severe renal impairment, cardiovascular events such as heart attack or stroke, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice signs of bleeding, sudden kidney problems, chest pain, or severe skin rash.

Momendol should be avoided in individuals with known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulcer or bleeding, severe heart failure, uncontrolled hypertension, and in patients with advanced renal or hepatic impairment unless specifically directed by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Naproxen Sodium

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT